Validation of Indicor Photoplethysmography (PPG) Valsalva Pulse Response vs Non-invasive Blood Pressure
Completed
Conditions studied: Heart Failure
In brief
This study designed is compare the pulse response to the Valsalva maneuver between a photoplethysmography sensor (PPG) and non-invasive blood pressure sensor for the purpose of validating the PPG methodology in deriving a value for the Valsalva pulse response. The aim is to show that the PPG method captures the same phase responses as the blood pressure monitor and the primary outcome is the correlation between pulse amplitude ratios for the pulse at the end of the Valsalva to an average baseline pulse.
Key facts
- Study ID
- NCT04665011
- Run by
- Vixiar Medical, Inc.
- People needed
- 121
- Starts
- 2020-12-14
- Expected to finish
- 2021-01-28
- Last updated by the study team
- 2021-03-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Clinically stable adults, including heart failure patients visiting an outpatient clinic
You may not qualify if…
- Atrial flutter or atrial fibrillation with an irregular ventricular response
- Significant atrial or ventricular ectopy
- History of paradoxical emboli
- Hypertrophic obstructive cardiomyopathy
- Known intracardiac shunt
- Known severe aortic valve stenosis
- Known severe mitral valve stenosis
- History of embolic CVA
- Myocardial infarction within one week of intended Indicor testing
- Uncontrolled hypertension (systolic BP >160mmHg or diastolic BP>100mmHg)
- Hypotension (systolic BP <90mmHg)
- Symptomatic bradycardia
- Known cholesterol emboli
- Poor left ventricular function with left ventricular thrombus
- Unstable angina
- Significant aortic valvular disease
- Patients weighing less than 40kg
Where it is running
- Fort Norfolk Cardiology Associates — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.